Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018

Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $105 on, May 25th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-105-on-may-25th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $101 to $105 on, May 25th, 2018.

Michelle has made no other calls on BMRN in the last 4 months.



There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Michelle


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Monday, April 30th, 2018
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $116 on, Friday, March 2nd, 2018
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $124 on, Friday, February 23rd, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $132 on, Friday, February 23rd, 2018
  • M. Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $125 on, Friday, February 23rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $102 on, Friday, February 23rd, 2018